ישראל - עברית - Ministry of Health

romat ltd - lincomycin hydrochloride 56.7 mg/ml; spectinomycin hydrochloride 150 mg/ml - solution for injection - for infections caused by the following bacteria: staphylocococcus spp, streptococcus spp, diplococcus spp., corynebacterium spp., bacillus spp.,clostridium spp., coliform bacteria, klebsiella spp., salmonella spp., haemophilus spp., brucella spp., pasteurella spp., leptospira spp., bordetella spp., coccidia, campylobacter spp., fusobacterium spp., treponema spp., mycoplasma spp. cattle: respiratory diseased, enteritis, foot infections, mastitis, clostridiosis, mycoplasmosis. swine: pneumonia (bacteria/mycoplasma), bloody scours, septic arthritis, bacterial enteritis, pneumonia (haemophilus).

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - posaconazole 100 mg - posaconazole

ישראל - עברית - Ministry of Health

ofek pharma ltd, israel - posaconazole - טבליות שחרור מושהה - posaconazole 100 mg - posaconazole